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What is the evidence that the clinical manifestation of an IgE-mediated allergic reaction is caused by ingestion of a particular tree nut species?
Which tree nut molecules are recognised by serum-IgE from tree nut allergic individuals and are responsible for causing an IgE-mediated adverse reaction to those foods? to systematically review the evidence regarding (1) which allergenic tree nuts should be included in food allergen labelling lists and (2) which are the clinically relevant allergens which should be used as analytical targets. A search strategy and criteria against which the evidence will be evaluated have been developed. The resulting evidence will be used to rank tree nuts with regards their ability to cause IgE-mediated allergies, and allergen molecules regarding their capacity to elicit an allergic reaction. The results of the systematic review will enable risk assessors and managers to identify tree nut species that should be included in food allergen labelling lists and ensure analytical methods for determination of allergens in foods are targeting appropriate molecules.
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Background
IgE-mediated food allergy affects approximately 1.5% of adults and 5-6% of children in Europe although most infants and young children "outgrow" their food allergy by school age (Nwaru et al., 2014) with tree nuts being estimated to cause around 0-1.9% of food allergies (McWilliam et al., 2015) . The prevalence of food allergy varies around the world, and whilst sensitisation to a wide variety of foods is high in countries like India, the prevalence of probable food allergy is low (Mahesh et al., 2016) and whilst differences in methodology may in part be responsible for these variations it is becoming clear that genetic and environmental factors also contribute (Rona et al., 2007 , Nwaru et al., 2014 , McWilliam et al., 2015 . Whilst more than 170 different foods have been reported to cause IgE-mediated allergic reactions, (Hefle et al., 1996) the majority of allergies are caused by a relatively small number of foods including egg, milk, fish, shellfish, peanut and tree nuts (Nwaru et al., 2014 , McWilliam et al., 2015 , Venter et al., 2016 . Since there is currently no accepted therapy for food allergy, individuals diagnosed with the condition must practise food avoidance, often life-long. Those individuals thought to be at risk of having a severe reaction are also given rescue medication such as anti-histamines and self-injectable adrenaline, should they accidentally consume some of their problem food.
In order to help allergic consumers avoid their problem food, a list of priority allergenic foods have to be labeled at whatever level they are included in a recipe, based on the foods listed in the Codex Alimentarius Commission labeling recommendations (CodexAlimentariusCommission, 1999) . The Codex list includes "tree nuts", although the specific plant species covered by this phrase are not always defined in regulations implemented across the world. In general expert opinion has been used to inform decisions as to which foods should be included in food allergen labeling lists, although systematic M A N U S C R I P T
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5 approaches have been proposed to identify allergenic foods of public health importance that must be actively managed (Bjorksten et al., 2008 , Houben et al., 2016b , van Bilsen et al., 2011 . In addition to mandatory labeling of allergenic ingredients, precautionary allergen labelling (PAL) may also be used to warn the allergic individual about the unintended presence of allergens through the use of phrases, such as "may contain" (DunnGalvin et al., 2015) . Effective analytical methodology is required to help support risk assessment and management of allergenic ingredients using approaches such as those developed by the Voluntary Incidental Trace Allergen Labelling (VITAL) expert group (Taylor et al., 2014) .
Analysis of allergens is used for both in validating cleaning protocols in factories as well as monitoring ingredients and finished foods for unintended allergens. However, there are many limitations with current allergen analysis (Walker et al., 2016) and it is not always clear which allergen molecules represent the hazard for allergic consumers and should be used as analytical targets for new methods, such as protein mass spectrometry.
We propose to undertake a systematic review of the literature to assess the strength of evidence supporting the inclusion of particular tree nut species in priority lists of allergenic foods, and to help identify clinically relevant allergenic molecules in those foods to be used as analytical targets in allergen analysis. (McWilliam et al., 2015 , Venter et al., 2016 . The application of systematic reviewing to food hazards, such as allergens, is relatively novel, and it is recognised that there is a need to adapt protocols used in medicine to the needs of evidence-based toxicology (Stephens et al., 2016) . We have developed a protocol for the systematic review built on an approach previously described for identifying allergenic foods of public health importance (Bjorksten et al., 2008 , Houben et al., 2016a , van Bilsen et al., 2011 . It is based on guidance provided by the European Food Safety Authority (EFSA, 2010) which draws on approaches developed in the health care field (Higgins and Green, 2011, CRD, 2009 ) and applies PRISMA guidelines (Moher et al., 2009) .
Study design
The primary question being addressed is "What is the evidence that the clinical manifestation of an IgE-mediated allergic reaction is caused by ingestion of a particular tree nut species?"
The secondary question being addressed is "Which tree nut molecules are recognised by serum-IgE from tree nut allergic individuals and are responsible for causing an IgEmediated adverse reaction to those foods?" The PO approach (shown in blue) will be used to answer the primary question "What is the evidence that the clinical manifestation of an IgE-mediated allergic reaction is caused by ingestion of a particular tree nut species?". A modified PECO approach (shown in green)
will be used to address the secondary question "Which tree nut molecules are recognised by serum-IgE from tree nut allergic individuals and are responsible for causing an IgEmediated adverse reaction to those foods?"
The primary question will be addressed using a PO approach (EFSA, 2010) the population (P) being the patient population evaluated for an IgE-mediated allergy to food and the outcome (O; or condition of interest) being whether they suffer from IgEmediated allergy to tree nuts ( Figure 1 ). The population can include patients drawn from either prospective cohort studies, longitudinal cohorts, or cross-sectional studies and case series. The outcome is then graded with regards the quality of diagnosis (test accuracy), based on the principals laid out in the EAACI Food Allergy Guidelines , Soares-Weiser et al., 2014 and criteria proposed by Bjorksten and co-workers (Bjorksten et al., 2008) . This will allow the quality of studies and the evidence that documented adverse reactions are caused by an IgE-mediated mechanism to be assessed and provide some indication of the severity of reactions.
The secondary question will be addressed using a modified population, exposure, comparator and outcome (PECO) (EFSA, 2010) approach (Table 1 ; Figure 1 ). In the modified approach the population is the one identified in addressing the primary question that has been classified as having either probable or confirmed food allergy. The exposure (E) element of PECO is taken as the exposure to tree nut allergens as indicated by the detection of tree-nut specific serum IgE and/or positive skin prick testing with tree nuts, tree-nut extracts or purified tree nut allergens. The test accuracy will be assessed in terms of the quality of the IgE binding studies performed together with the quality of the allergen extracts and purified allergens used. The comparison (C) is then made with regards the prevalence of sensitisation to the different allergen molecules in the population (P). The allergens will also be compared with regards their potency as indicated by their ability to bind IgE or trigger mediator release in an effector cell assay, such as the stripped-basophil histamine release assay. The outcome [O] relates to the evidence indicating that a particular allergen molecule is responsible for eliciting IgE- 
Outcomes (O)
What is the quality of evidence that a particular molecule can cause an IgE-mediated reaction? mediated allergic reactions in the population. If data are of sufficient quality, some indication of their potency may also be assessed through a meta-analysis of outcomes, such as skin prick test wheal diameter or levels of allergen specific IgE.
Search strategy
Initially a list of tree nuts included in allergen labelling legislation in Europe, USA and other jurisdictions was compiled (Supplementary file 1). Currently 31 countries and one jurisdiction in the world have implemented food allergen labelling regulations, and three countries have proposed a food allergen legislation draft for consideration. Several have M A N U S C R I P T
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10 listed specific tree nut species and these were used as the basis to defining the search terms (Table 2 ). These search terms will be applied with validated study designed filters for retrieving any other relevant systematic reviews (Wilczynski and Haynes, 2007) and sound diagnostic studies (Wilczynski and Haynes, 2005) and used to search MEDLINE (OVID), ISI Web of Science, and Scopus (Falagas et al., 2008 ) from inception to 30-August-2017. Additional references will be located through searching the allergenic food database InformAll, a searchable technical database for food allergy (plant and animal allergenic foods), hosted by the University of Manchester and based on peer reviewed articles which have been reviewed by a panel of expert referees (InformAll). This will be complimented by searching the references cited in the papers identified in the search, technical reports and other literature that has not been peer reviewed but is publicly available. The database will be searched without language restrictions. If the abstract of a non-English article is identified as being relevant, where possible, it will be translated into English. The research process will be fully documented to will allow the search to be assessed and reproduced. 
Study selection
Articles identified in the searches will be evaluated against inclusion and exclusion criteria defined in Table 3 . All references will be uploaded into EndNote and duplicate copies of the same article be removed using a combination of automatic (using software such as Distiller) and manual screening. Study titles and abstracts will be independently reviewed by two team members (BJ, ENCM) using the selection criteria described above and categorised as included, excluded, and unsure. The full text of research studies in the unsure category will be retrieved and re-categorised as included or excluded. Discrepancies will be resolved by discussion with the whole team (BJ, ENCM, AS, PP and MS). 
Inclusion Exclusion
(i) Peer-reviewed articles.
(ii) Articles directly related to the defined research questions. (ii) Studies that do not describe the IgEbinding molecules or are unrelated to the question being addressed.
(iii) The abstract and summary of the following will not be included in the study: book chapters, non-peer reviewed case reports or case studies, (iv) Review articles.
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(v) Animal model studies.
Quality assessment strategy
Tabulation will be used to make a summary for exploring the differences and similarities between the studies and studies will be ranked as described in Table 4 . Quality assessment of each study will be carried out independently using the Critical Appraisal Skill Program check-lists (CASP).
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14 Table 4 : Criteria for assessing the quality of evidence that a population is sensitised to a particular allergenic tree nut or allergen molecule.
To assess the risk of bias in the studies, the Cochrane guideline will be used to examine each secondary study (Higgins and Green, 2011) . During the review of secondary studies, a numerical scaling approach was developed to allow weighting of the contribution made by a particular line of evidence to the overall estimate (i.e. a single scale or score). Clarification was provided for each level of evidence (lowest to highest). The grading will be performed independently by two people (BJ, ENCM) and a justification for each of the scores given to each paper will be noted and compared at the end through open discussion with the whole study team (BJ, ENCM, AS, PP and MS). The grading criteria developed uses four key questions and indicative scores given to each category as follows. 
Quality level Criteria
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The population under study: The highest quality grade will be given to those patients who have confirmed food allergy with an oral food challenge or a history of anaphylaxis following consumption tree nuts, and associated sensitisation to the relevant food, taking into account the quality measure of the study as defined by Bjorksten et al (Bjorksten et al., 2008) (Tables 4 and 5) . A lower quality grade will be given to those patients who had evidence of sensitisation to the relevant food and a convincing history of a reaction within 2h of consuming their problem food [probably food allergy]. The lowest grading will be given to patients for whom data are only available regarding either their self-reported allergy to tree nuts or sensitisation to tree nuts determined either by measurement of specific IgE or skin prick testing [possible food allergy].
The exposure under study: The concept of exposure relates to identifying how many subjects in the population with tree nut allergy have been exposed to a particular molecule from a given tree nut species (or a closely homologous molecule) and developed serum-IgE to that molecule. Two types of test accuracy will be applied, one that relates to the quality of the allergen preparations used (Table 6 ) and a second which relates to the methodology used to assess IgE binding (Table 7) . 
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• Convincing history with symptoms consistent with an IgEmediated allergic reaction or;
• Sensitisation alone, proven using specific IgE testing or a skin prick test [possible food allergy].
4
No evidence of causing IgE-mediated allergies. To evaluate the quality of the allergen preparation, it is important to know what type of allergen preparation has been used in the study (is it a crude allergen extract, native purified protein or recombinant protein?). It is also relevant to assess an allergen's folded state and any aggregation or postranslational modifications which could affect the IgE binding ability of the allergen molecule (Hoffmann-Sommergruber et al., 2008) .
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The quality of the methodology used to determine a molecules capacity to bind IgE also needs to be considered (Table 7) . In vivo tests include oral or labial challenges and skin testing (i.e. skin prick test and prick-to-prick test) whereas in vitro tests include effector cell activation using mast cells, basophils (patient's own or stripped basophils) and ImmunoCAP and ISAC, and immunoblotting methods. Each method has its own performance parameters (including sensitivity and specificity). Since in vivo methodologies were ranked more highly than the in vitro tests and since the effector cells include a measure of the ability of an allergen to trigger histamine release and is biologically more closely related to the events occurring in an allergic reaction, these in vitro tests were ranked more highly than those simply measuring food specific IgE. 
The comparators under study: The capacity of the different allergen molecules to sensitise a given tree nut allergic population (P) and their potency. Aspects relating to the prevalence of sensitisation will be assessed, taking into account the quality of studies using the grading scheme proposed by Bjorksten et al (Bjorksten et al., 2008) . Depending on the quality of data available, potency could be defined in terms of kUIgE/L that bind to a specific allergen, the concentration of allergen able to either inhibit IgE binding by 50% in an inhibition immunoassay or initiate 50% of mediator release in an effector cell assay or skin prick test mean wheal diameter, which can be used to assign a biological potency to an allergen with regards its capacity to elicit an IgE-mediated allergic reaction used as a comparator.
Analysis and reporting of outcomes:
Using an aggregated score based on the grading for P and O measures for different tree nuts will allow them to be ranked according to the evidence that they can cause IgE-mediated food allergies and therefore whether they should be included on allergen labelling lists. If the quality of evidence allows, data on measures of potency (e.g. severity of reaction and sensitivity using threshold dose distributions) (Bjorksten et al., 2008) will be integrated with data on prevalence to classify the tree nuts as major, minor or emerging allergenic foods. The outcome of this analysis will show whether a particular tree nut can be identified as causing IgE-mediated allergic reactions. However, before including such foods in food allergen labelling lists other factors need to be taken into account, such as the risk of exposure as indicated by the extent of use and whether a food ingredient can be considered as a "hidden allergen" not readily discerned by the allergic consumer (Bjorksten et al., 2008) . If data of sufficient quality and quantity are samples from food allergic patients.
6 Dot blotting using allergen extracts and serum samples from food allergic patients.
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20 identified, allergen molecules will be ranked with regards the extent to which they sensitise the tree-nut allergic population and their potency, allowing an evidence-based means of selecting the most hazardous allergenic molecules which should be included as targets for allergen analysis.
Pilot study
A pilot study was conducted to validate and evaluate the review protocol to make sure that the process is rigorous, transparent and replicable.
Discussion
This framework will provide an objective way of assessing the quality of evidence that particular foods can cause IgE-mediated food allergies and subsequently to rank them. Other approaches have been developed using more complex and detailed data such as prevalence, threshold data and impact on quality of life (Houben et al., 2016a) . The simplified approach taken in this systematic review may provide a means of ranking foods objectively for which such data are lacking and help support the decision making and prioritisation with regards elaborating the list of tree nut species that should be labelled. The analysis will also allow an evidence-based approach to be taken to identifying allergenic molecules as analytical targets which represent the true hazard for allergic consumers. During the course of the analysis data gaps will be identified. 
